Front. Cell. Neurosci., 2018 · DOI: 10.3389/fncel.2018.00368 · Published: October 16, 2018
Spinal cord injury triggers inflammation, driven by microglia and macrophages. The study investigates whether modulating these cells can be a therapy. Researchers used a drug (GW2580) to inhibit CSF1R, a receptor that regulates microglia/macrophage proliferation in mice with spinal cord injury. The drug reduced microglia proliferation, improved motor recovery, reduced gliosis (scarring), and lessened microcavity formation after spinal cord injury.
Inhibiting microglia proliferation after spinal cord injury may be a viable therapeutic approach.
Targeting microglia proliferation could help limit neuroinflammation following SCI.
Reducing microglia proliferation may promote tissue preservation in the injured spinal cord.